To investigate the association between butyrylcholinesterase (BChE) activities (total and band specific) and body mass index (BMI) in obese and nonobese individuals, considering other variables (anthropometric, biochemical and hormonal) and the leanness process. SUBJECTS: Obese (BMIZ30 kg/m 2 ; N ¼ 181) and nonobese individuals (N ¼ 265), classified according to the CHE2 locus phenotypes, with the obese patients being followed-up when submitted to a weight-loss program. MEASUREMENTS: Anthropometric (weight, height, BMI, waist, waist/hip ratioFWHR, triceps and subscapular skinfolds, percentage of body fat and arterial pressures), hormonal (insulin, estradiolFE 2 , triiodothyronineFT 3 and thyroxineFT 4 ) and biochemical (glucose, total cholesterol, HDL-C, triglycerides, uric acid, urea, creatinine, sodium, potassium and BChE activities) variables. RESULTS: Although obese CHE2 C5À individuals presented higher mean BChE activities than their CHE2 C5À controls and diminished mean activities with leanness, similar comparisons did not show any difference in the CHE2 C5 þ group. Furthermore, the mean serum potassium values of obese individuals were significantly higher in the CHE2 C5 þ than in the CHE2 C5À phenotype. The BChE activities were less related to BMI in obese CHE2 C5À individuals than in their controls. In the CHE2 C5À obese group, significant regression coefficients were found between BChE activity variables and BMI ( þ ), ethnic origin (higher in Euro-Brazilians), sex (higher in males), diastolic pressure (À), triceps skinfold ( þ ), total cholesterol ( þ ), T 3 ( þ ) and E 2 (À). The main findings in the CHE2 C5 þ obese group: mean insulin levels decreased with leanness and a significant correlation was detected between the C 5 complex activity and creatinine ( þ ), insulin (À) and WHR (À); a significantly higher frequency of weight loss occurred compared to the CHE2 C5À group. CONCLUSION: In the present study, different relations between obesity and some of the studied variables were found when CHE2 C5 þ and CHE2 C5À individuals were compared.
Introduction
Human butyrylcholinesterase (BChE; EC 3.1.1.8) occurs in molecules consisting only of BChE (monomer to tetramer) or of BChE linked to another substance. The genetic variation of BChE is conditioned by alleles at two loci (BCHE and CHE2). The BCHE gene is responsible for the amino-acid sequence of this enzyme and has been characterized at the DNA level. 1 Some of its phenotypes may be identified by enzymatic inhibition tests, and those prevalent in population studies are BCHE U (usual), BCHE UA (heterozygous for the atypical variant) and BCHE UF (heterozygous for one of the fluoride-resistant alleles). The CHE2 locus presents two alleles (CHE2*C5 þ and CHE2*C5À) and determines the CHE2 C5 þ (about 10% of the general population) and CHE2 C5À phenotypes, characterized by the presence and absence of the C 5 complex, respectively. This complexFidentified as an electrophoretic bandFis formed by the BChE tetramer (C 4 ) linked to a still unidentified molecule 2 conditioned by the CHE2 locus.
It received this denomination in view of similar mobility to either C 4 or C 5 , depending on the pH of the agar gel used. Although the physiological role of BChE remains unknown, many data have been reported on the association of BChE activity with weight and body mass index (BMI). BChE activity is positively correlated with subcutaneous fat 4 and with weight. [5] [6] [7] [8] [9] A positive association between BMI and the activity of the C 4/5 complex of BChE was also reported. 10 In the case of the CHE2 gene that interacts with the BCHE gene to form the C 5 complex, it was shown that CHE2 C5 þ individuals present a significantly lower mean weight 9 and a significantly lower mean BMI 11 than their CHE2 C5À controls. Obesity (BMIZ30 kg/m 2 ) is a common and serious medical problem throughout the world associated with complications such as diabetes mellitus, cardiovascular diseases, cancers, gastrointestinal diseases and arthritis. Considering the positive associations of BChE activities with weight and BMI and the respective negative associations found when the CHE2 C5 þ phenotype is examined for these two variables, the aim of the present study was to verify BChE activities and BMI in obese and nonobese individualsFclassified according to the CHE2 locus phenotypeFand also follow up those obese individuals submitted to a weight-loss program. We also evaluated hormonal and other anthropometric and biochemical variables that may be related to the BChE activities and/or to BMI. 14 was measured with a spectrophotometer (410 nm) at 251C with modifications, 15 using propionylthiocholine as substrate. Partial BChE activities were also measured: relative (R) activity of a band (% of the activity of this band in the gel, using alpha-naphthyl acetate as substrate, as measured by the densitometer), absolute (A) activity of a band (relative activity of this band multiplied by total activity). The activities of the C 4/5 bands of the CHE2 C5 þ phenotype were estimated by the difference between the C OF activities obtained after electrophoreses at pH 6.5 and 5.3, since in this phenotype C 4/5 is part of C OF at pH 6.5 ( Figure 1 ). Butyrylcholinesterase and obesity VM Alcântara et al
Methods

Subjects
Statistical analysis
STATISTICA programs (STATSOFT, 1996) 16 were used for the analyses. In view of the lack of information about biochemical exams for part of the sample, some criteria were followed when these data were considered in the stepwise multiple regression analyses: (a) to consider the maximum number of individuals and of independent variables, and (b) keeping the independent variables in the analyses only when the regression coefficients were statistically significant. Some of the variables were coded as follows: sex (0 ¼ women, 1 ¼ men), ethnic origin (1 ¼ Euro-Brazilians, 2 ¼ Afro-Brazilians). Arterial pressure (mmHg) was coded as 1 (systolic o140 and diastolic o90), 2 (systolic Z140 and diastolic o90), 3 (systolic o140 and diastolic Z90) and 4 (systolic Z140 and diastolic Z90).
Results and discussion Table 1 shows the mean values of all the variables analyzed in obese and control individuals, except those referring to the BChE activity variables, which are presented in Table 2 . Comparing the data in Table 1 , apart from the higher mean weight and BMI expected for obese individuals, we also observed that CHE2 C5À obese individuals presented significantly higher mean age, systolic and diastolic pressures, uric acid, urea, glucose, triglycerides and insulin, and lower mean height when compared to the nonobese individuals of the same phenotype by t-tests. In the case of the CHE2 C5 þ phenotype, the obese individuals presented significantly higher mean age, systolic and diastolic pressures, insulin and E 2 (in log scale), and lower mean height than nonobese individuals. Apart from the E 2 means, all the other means showed similar results in the CHE2 C5À and CHE2 C5 þ phenotypes. Although obese and nonobese individuals of the CHE2 C5 þ phenotype did not show statistically significant different means for uric acid, urea, glucose and triglycerides, this may be due to the small number of analyzed individuals, since the face values are in the same direction as those found for the CHE2 C5À phenotype. When the t-test comparisons were made between obese individuals of the CHE2 C5À and CHE2 C5 þ phenotypes, the latter group showed significantly (Po0.05) higher mean potassium and E 2 levels (in log scale).
When the mean values for the BChE activity variables were compared between obese and nonobese individuals, statistically significant differences were only shown in the case of the CHE2 C5À phenotype (Table 2) , with higher means being obtained for obese patients than for nonobese individuals. No change was detected in these comparisons when 93 CHE2 C5À and 15 CHE2 C5 þ obese individuals were paired by variables that influence BChE activities (sex, age and ethnic origin) to their respective nonobese controls of the same phenotype. With the exclusion of one BCHE UA individual from the 16 CHE2 C5 þ obese individuals (Table 2) , mean total BChE activities were 5.8370.97 and It is a well-known fact that the CHE2 C5 þ phenotype presents higher mean BChE total activity than the CHE2 C5À phenotype as shown in samples from different general populations. 5, 9, 11, [20] [21] [22] Although this difference between the mean BChE activities of these two phenotypes occurs in the general population, the data in Table 2 show that there was no difference in total mean BChE activity between CHE2 C5 þ and CHE2 C5À obese individuals (t ¼ 0.07; P40.90). In a previous study on CHE2 C5 þ individuals from a population sample, positive correlations between weight and total and AC OF BChE activities were shown. 11 As the present data on the CHE2 C5 þ obese individuals did not show this same trend and considering that the present result would not change in a larger sample, a possible reason for this different behavior will be discussed later. Although the BChE activity variables in the CHE2 C5À obese and nonobese samples presented statistically significant standardized regression coefficients with weight, height, ethnic origin and sex (Table 3A) , the variances of these BChE variables were less explained in obese than in nonobese individuals, as shown by the r 2 values. Further regression analyses with the obese sample (Table 3B) showed increase of the r 2 values with the inclusion of other independent variables (total cholesterol, T 3 and E 2 ) in the models. Positive correlations between total BChE activity and total cholesterol levels have already been shown. 6, 18, 23 An increase in total BChE activity has already been detected in hyperthyroidism. 24, 25 The negative correlation with E 2 is supported by data showing higher mean total BChE activity in men than in women in the fertile period, a difference that disappears after menopause. 26, 27 A decrease of total BChE activity was also reported during pregnancy when an increased synthesis of estrogens occurs. [28] [29] [30] [31] So, the higher mean E 2 level found in the CHE2 C5 þ obese individuals of the present study when compared to the CHE2 C5 þ controls and to the CHE2 C5À obese individuals (Table 1) may be the reason why the CHE2 C5 þ obese patients did not show the expected significantly higher mean BChE activities when compared to each of these two groups ( Table 2 ). The relative activity of C 4/5 (RC 4/5 ) showed statistically significant regression coefficients (Table 3B ) with diastolic pressure (À) and triceps skinfold ( þ ). Since diastolic pressure is associated with peripheral vascular resistance, one can suggest that the substance linked to BChE in the C 4/5 complex could be related to vasodilatation or to inhibition of vasoconstriction.
When BMI was considered as a dependent variable in the multiple regression analyses (Table 4) , its variance was better explained (r 2 ) in nonobese than in obese individuals.
Different positive associations with the BChE activity variables and BMI were observed in nonobese (AC 4/5 ) and obese (AC OF ) individuals. The data in Tables 3 and 4 suggest that physiological factors associated with obesity may lead to a decrease in the correlations between the BChE activity variables and BMI, weight, height, age and sex when obese individuals are compared to nonobese individuals. In the CHE2 C5À obese group (Table 4B) , BMI shows positive standardized regression coefficients with arterial pressure, (Table 4A ) explained a very small part of the BMI variance in the obese individuals. In these CHE2 C5À individuals, BMI correlates more with the metabolic changes related to obesity than to the BChE activity variables. These activities seem to be dependent on these metabolic changes.
A total of 153 CHE2 C5À individuals were followed up for weight evaluation: 21.6% lost weight (from 4 to 22%) and 2.6% gained weight (from 4 to 8%). Mean total and C 4/5 BChE activities for the 37 CHE2 C5À obese individuals who showed weight modification were significantly higher when these individuals were heavier (Table 5) . A 9% decrease in weight was accompanied by a 14% reduction of AC 4/5 , suggesting that the expression of this complex is dependent on weight and/or on factors related to it. When mean biochemical and hormonal data (except E 2 ) were compared between these two periods, no significant difference was observed. These BChE activity variables may seem more susceptible to weight modification than the other variables considered. However, not all of the 37 individuals Butyrylcholinesterase and obesity VM Alcântara et al presented information about the biochemical variables, this probably being the reason for the lack of a significant change in these means. Face values of the means of total cholesterol and T 3 levels showed a decrease with the leanness process (P40.10 and 0.20, respectively). On the basis of data presented in Table 3B , our hypothesis is that the weight modification and these two trends taken together may be responsible for the decrease in the observed total and AC 4/5 mean activities of the CHE2 C5À obese individuals. The frequency of the CHE2 C5 þ phenotype in the obese individuals ascertained at the Obese Ambulatory (9.52%72.26%) did not differ (w 2 (1) ¼ 0.09; P40.70) from the frequency reported for the general population of Curitiba (10.23%70.60%). 9 In the case of the CHE2 C5 þ obese individuals, 43.8% had ARC 5 of intense phenotype when classified according to the median (7.6%) found in the nonobese control sample. The distributions of the CHE2 C5 þ phenotypes (intense and faint C 5 band) did not differ when obese individuals were compared to nonobese individuals (w 2 (1) ¼ 0.19; P40.60). Considering weight modification, 56% of the CHE2 C5 þ individuals lost weight (86% of the intense CHE2 C5 þ individuals (N ¼ 7) lost weight and 33 and 11% of the faint CHE2 C5 þ individuals (N ¼ 9) lost and gained weight, respectively). The frequency of individuals who lost weight was statistically higher in the CHE2 C5 þ group (w 2 (1) ¼ 7.56; Po0.01) than in the CHE2 C5À group. So, the presence of the CHE2*C5 þ allele may predispose to a better performance for losing weight.
The means of the BChE activity variables detected in the CHE2 C5 þ group did not differ when these individuals presented a weight change. Although this is a small sample, it seems that weight modifications do not alter the BChE activities in this phenotype, in contrast to what was observed in the CHE2 C5À group.
Correlation coefficients between the BChE activity variables and those included in Table 1 were calculated for CHE2 C5 þ obese individuals, and the significant r values are presented in Table 6 . The negative correlation found for C 5 and WHR indicates that the faint CHE2 C5 þ phenotype is associated with the android type of obesity, which presents higher risk of coronary artery disease. 32 The positive correlation between C 5 complex activity and creatinine is possibly related to muscle mass. Although an increase in blood creatinine may depend on the impairment of renal filtration, it is well known that creatinine synthesis is a primary function of total muscle mass, being relatively constant with stable muscle mass. 33 The correlation coefficients found when T 3 and E 2 were considered showed the same direction as those found for the CHE2 C5À obese individuals (Table 3B) .
Insulin is shown to be negatively associated with the relative activity of the C 5 complex (Table 6 ). In the 10 individuals who showed weight modification, only the BChE activity variables, T 3 , T 4 , TSH and insulin were compared Table 7 shows that this decrease occurred in the majority of the CHE2 C5 þ obese individuals. Since no difference in this hormone level was verified in the CHE2 C5À phenotype during leanness, it seems that this physiologic process may differ in these two phenotypes in relation to the insulin level. The negative correlation between the plasma levels of insulin and potassium is well known. 33 It is possible that the tendency to a lower mean insulin level in CHE2 C5 þ obese individuals may be related to the significant higher mean potassium level found in the obese CHE2 C5 þ phenotype when compared to the CHE2 C5À phenotype (Table 1) . Obese CHE2 C5 þ and CHE2 C5À individuals seem to present different behaviors with respect to BChE activities, weight loss and potassium level. Furthermore, the relations found for the activity of the C 5 complex of BChE with WHR, insulin and creatinine deserves further investigation.
Since the C 5 complex is formed by the BChE tetramer linked to a molecule conditioned by the CHE2 locus, it is interesting to point out that the 2001 update review of the human obesity gene map 34 shows rodent quantitative trait loci related to obesity that present putative syntenic relationships with the locations of the BCHE (3q26.1-q26.2: Afp2Fabdominal fat; Hlq3 and Hlq4Fheat loss; Qlw3Flate weight gain; Dmo9Fadipose index) and CHE2 genes (2q33-q35: Fob1Ffat; Nidd5Fbody weight; Obq3 and Obq7Fobesity; Bw5Fbody weight; Nzoq2Fleptin/ BMI; Mob6 and Mob7Fsubcutaneous fat) in humans. Butyrylcholinesterase and obesity VM Alcântara et al
